Thursday, July 18
  • Vol 8, Issue 14

  • A Women's Health Initiative study of a combination of the hormones estrogen and progestin, prescribed under the brand Prempro, was stopped early because of results indicating that the form of HRT increases risk of breast cancer and other diseases. Photo by Clay Eals

    Science Articles
    General Articles

    Briefs

    Credits


    Fred Hutchinson Cancer Research Center
    1100 Fairview Ave. N. PO Box 19024 Seattle, WA 98109
    ©2009 Fred Hutchinson Cancer Research Center, a nonprofit organization.
    Terms of Use & Privacy Policy.

    CenterNetCheck E-mail